Search Results

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 18

A PHASE 0/1 STUDY OF COMBINATION DRUG THERAPY FOR GLIOBLASTOMA BASED ON PERSONALIZED CANCER STEM CELL (CSC) HIGH-THROUGHPUT DRUG SCREENING

A study to determine the safety of CSC/ HTS-based combination drug therapy in subjects who have GBM that has recurred or progressed following prior...

Charles S. Cobbs, MD

A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl Fumarate

This study will assess the gastrointestinal (GI) tolerability of ALKS 8700 in adult subjects with RRMS.

James Bowen, MD

Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab

The primary objective of this study is to assess the efficacy of Ocrelizumab (OCR) in Relapsing Multiple Sclerosis patients who have been...

Pavle Repovic

A Phase III Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

The primary objective of this study is to evaluate progression-free-survival in patients receiving DCVax-Brain to treat GBM.

Charles Cobbs, MD

A Randomized Controlled Trial of Vitamin D Supplementation in Multiple Sclerosis.

Low vitamin D levels have been shown to increase a person's risk of developing multiple sclerosis (MS), and patients with MS who have lower vitamin...

Peiqing Qian, MD

Lipoic acid for Treatment of Progressive Multiple Sclerosis

This two-year study will determine if daily oral intake of lipoic acid will prove superior to placebo in reducing injury to the brain and...

Pavle Repovic, MD

North American Registry for Care and Reserach in Multiple Sclerosis

North American Registry for Care and Research in Multiple Sclerosis towards the development of a North American Longitudinal Database in Multiple...

Dr. Pavel Repovic

Consonance - AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple...

Pavle Repovic, MD
« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 18